Operating Lease, Liability of Vitro Biopharma, Inc. from 31 Jan 2023 to 31 Oct 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Vitro Biopharma, Inc. quarterly Operating Lease, Liability in USD history and change rate from 31 Jan 2023 to 31 Oct 2025.
Vitro Biopharma, Inc. Operating Lease, Liability for the quarter ending 31 Oct 2025 was $360,681, a 4.2% increase year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Change (%)

Vitro Biopharma, Inc. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$360,681	+$14,590	+4.2%	31 Oct 2025	10-K	13 Feb 2026	2025	FY
Q2 2025	$255,658	-$122,139	-32%	31 Jul 2025	10-Q	12 Sep 2025	2025	Q3
Q1 2025	$285,130	-$124,770	-30%	30 Apr 2025	10-Q	20 Jun 2025	2025	Q2
Q4 2024	$315,209	-$127,425	-29%	31 Jan 2025	10-Q	20 Mar 2025	2025	Q1
Q3 2024	$346,091	-$130,150	-27%	31 Oct 2024	10-K	28 Jan 2025	2024	FY
Q2 2024	$377,797	+$106,401	+39%	31 Jul 2024	10-Q	16 Sep 2024	2024	Q3
Q1 2024	$409,900	+$158,206	+63%	30 Apr 2024	10-Q	31 May 2024	2024	Q2
Q4 2023	$442,634	+$178,267	+67%	31 Jan 2024	10-Q	14 Mar 2024	2024	Q1
Q3 2023	$476,241			31 Oct 2023	10-K	29 Jan 2024	2023	FY
Q2 2023	$271,396			31 May 2023	10-K	13 Feb 2026	2025	FY
Q1 2023	$251,694			30 Apr 2023	10-Q	13 Jun 2023	2023	Q2
Q4 2022	$264,367			31 Jan 2023	10-Q	14 Mar 2023	2023	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.